Covaxin Has Reached "30 Cities In 30 Days," Says Vaccine Maker

Last week, Suchitra Ella had tweeted that Bharat Biotech is looking at ramping up the production of homegrown Covaxin

Bharat Biotech's homegrown Covaxin has reached 30 cities in 30 days, the vaccine maker said this morning in a tweet as shortage of doses continues to be a challenge in India's fight against coronavirus. Delhi and Punjab have said their requests have been turned down by US firms - Pfizer and Moderna - and the international pharma giants have insisted on dealing directly with the central government. COVAXIN reaches 30 cities within 30 day????????All Our employees are committed, working 24x7 thru lockdowns for the country's immunisation - pls send your prayers to their families,Some are still quarantined & off work. ????????????????????????????↔️5️⃣ft. pic.twitter.com/dfmnNGREbo Glad to share a very positive development from us 20/5/21 ???????? pic.twitter.com/cA3ZZx8pdc "COVAXIN reaches 30 cities within 30 day. All our employees are committed, working 24x7 thru lockdowns for the country's immunisation - pls send your prayers to their families, Some are still quarantined & off work (sic)," tweeted Suchitra Ella, the Co-Founder and Joint Managing Director of the Hyderabad-based firm. Last week, Ms Ella had tweeted that Bharat Biotech is looking at ramping up the production of homegrown Covaxin with another plant in Gujarat. The firm plans to "produce 200 million doses of Covaxin per annum" in the facilities already operational, a statement she shared on Twitter said.